Blog - Page 3 of 5652 - QualityStocks

WednesdayJun 03, 2026 9:50 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Drug Delivery and Platform-Based Biotech Innovation

Oncotelic Therapeutics (OTCQB: OTLC) was featured in a BioMedWire editorial exploring how biotechnology companies are increasingly leveraging advanced drug-delivery technologies, nanotechnology platforms and artificial intelligence to enhance existing therapies and expand treatment opportunities. The article highlights Oncotelic’s Sapu003 program, Deciparticle(TM) platform and PDAOAI initiative as part of a broader industry trend toward scalable, multi-application biotechnology platforms capable of supporting oncology and rare disease programs. The editorial also discusses developments from CytoDyn Inc. (OTCQB: CYDY), which is advancing leronlimab for oncology indications; Revolution Medicines Inc. (NASDAQ: RVMD), which reported positive Phase 3 results for daraxonrasib in pancreatic cancer; Moderna Inc. (NASDAQ:…

WednesdayJun 03, 2026 9:45 am

Earth Science Tech Inc. (ETST) Pairs Healthcare Expansion with Aggressive Share Repurchases

Earth Science Tech has evolved into a diversified healthcare holding company with operations spanning telemedicine, compounding pharmacies, clinical support services and healthcare fulfillment. In addition, the company has actively reduced its share count through a series of share repurchases documented in SEC filings and share structure records. Earth Science Tech repurchased 3.7 million shares over the nine months ended December 31, 2025, spending approximately $647,000. Management continues to emphasize shareholder value through balance-sheet management alongside acquisitions and operating growth. The company is scheduled to present to investors at the Planet MicroCap Las Vegas 2026 conference in June. For many investors…

WednesdayJun 03, 2026 9:40 am

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Featured in AINewsWire Editorial on AI Energy Demand and Natural Hydrogen Opportunity

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) was featured in an AINewsWire editorial examining how surging electricity demand from artificial intelligence infrastructure is accelerating interest in natural hydrogen as a potential large-scale energy solution. The article highlights MAX Power’s Lawson Project in Saskatchewan, where the company has confirmed North America’s first subsurface natural hydrogen system, and discusses its efforts to advance commercial evaluation of natural hydrogen as a potential source of scalable, off-grid baseload power for future AI and industrial applications. The…

WednesdayJun 03, 2026 9:30 am

QualityStocksNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML)

Canada News Group News Commentary Issued on behalf of Greenland Mines Ltd Greenland Mines (NASDAQ: GRML) is expanding its position in the critical minerals sector through the advancement of its Skaergaard palladium-gold-platinum project in Greenland and its planned acquisition of the Sarfartoq neodymium-praseodymium ("NdPr") rare-earths project. According to company disclosures, Skaergaard hosts a substantial palladium-equivalent resource and recently demonstrated significant metal-price leverage in an independent sensitivity study by SLR Consulting, while the Sarfartoq transaction would add an advanced rare-earths asset to the company's portfolio and establish Neo Performance Materials as a strategic shareholder and future offtake partner. Greenland Mines joins…

WednesdayJun 03, 2026 9:20 am

QualityStocksNewsBreaks – Dollar Holds Near Multi-Week Range as Markets Monitor U.S.-Iran Negotiations

Dollar index remained near 99.2, trading within a narrow range since mid-May. Investors watched developments in U.S.-Iran negotiations and the potential reopening of the Strait of Hormuz. Yen hovered near 160 per dollar, a level widely viewed as a potential trigger for Japanese intervention. According to a Reuters report by Hannah Lang and Stefano Rebaudo, with additional reporting by Satoshi Sugiyama, the U.S. dollar traded in a tight range Tuesday as investors monitored developments in ongoing U.S.-Iran negotiations and the potential reopening of the Strait of Hormuz, a key global oil shipping route. Market participants remained cautious amid uncertainty surrounding the…

WednesdayJun 03, 2026 9:10 am

QualityStocksNewsBreaks – SOLOWIN HOLDINGS (NASDAQ: AXG) Subsidiary Receives Bahrain Stablecoin Issuer License

SOLOWIN HOLDINGS (NASDAQ: AXG) announced that AX Coin Bahrain B.S.C. (c), its stablecoin issuance subsidiary, has received approval from the Central Bank of Bahrain to conduct stablecoin issuer activities. The company said AX Coin is the first entity licensed under the regulator's stablecoin framework, positioning it among a select group of stablecoin issuers operating under sovereign central bank oversight. SOLOWIN HOLDINGS (Nasdaq: AXG) said the approval provides a regulated foundation for expanding stablecoin-based financial infrastructure and supports the integration of digital assets into payments and settlement systems. Company executives said the license will enable AX Coin to scale compliant stablecoin…

WednesdayJun 03, 2026 9:00 am

QualityStocksNewsBreaks – Proposed Rollback of AI Health Care Safeguards Sparks Debate Over Innovation and Patient Safety

Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG) and other developers of health care AI systems could be affected by proposed Department of Health and Human Services rule changes that would ease longstanding requirements governing the design, testing and transparency of medical software. Supporters argue that reducing mandates for clinician testing and disclosure of training data could accelerate innovation, expand competition and lower costs for hospitals and health systems. Critics, however, warn that weakening safeguards may increase the risk of poorly designed tools entering the market, potentially creating confusion for clinicians, reducing efficiency and increasing the likelihood of medical errors. As policymakers weigh…

WednesdayJun 03, 2026 9:00 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Builds Diversified Pipeline Across Neurological and Wellness Markets

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. The growing burden of neurological disease has intensified industry-wide interest in therapies capable of protecting neurons, preserving brain function and addressing disease progression at a biological level. Quantum BioPharma’s flagship pharmaceutical subsidiary, Lucid Psycheceuticals Inc., is advancing LUCID-MS, a patented new chemical entity being developed for an unmet need in multiple sclerosis. The company has also expanded its presence in a consumer ready product in the field of alcohol health and sobriety through its involvement with unbuzzd(TM), an innovative, clinically validated alcohol metabolism accelerator…

TuesdayJun 02, 2026 3:00 pm

QualityStocksNewsBreaks – AI-Powered Wearables Transform Patient Monitoring and Clinical Decision-Making

Apple Inc. (NASDAQ: AAPL) and other wearable-device developers are positioned to benefit as advances in artificial intelligence and edge computing turn health care wearables into powerful clinical tools capable of delivering real-time, actionable insights rather than overwhelming streams of raw data. By continuously analyzing information collected from patients, AI-powered wearables can help clinicians identify meaningful trends, support remote patient monitoring, improve access to care in underserved areas and reduce the burden on already stretched health care professionals. While challenges remain—including the need for hospitals to modernize systems designed for episodic patient visits—the growing ability of wearables to provide a more…

TuesdayJun 02, 2026 2:39 pm

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Cancer Drug Delivery Technologies

Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how biotechnology companies are increasingly focusing on advanced drug delivery technologies to enhance the effectiveness of existing cancer therapies. The article highlights growing industry interest in nanoparticle delivery systems, intravenous reformulations and precision pharmacokinetic approaches designed to improve bioavailability, systemic exposure, tolerability and dosing consistency. The editorial notes that Oncotelic is advancing its Sapu003 program and Deciparticle(TM) platform as part of a broader trend toward nanotechnology-enabled drug delivery and AI-enhanced biomedical infrastructure. The company’s strategy focuses on developing platform technologies with potential applications across multiple oncology and rare disease indications rather than relying on a single therapeutic…

Site Search

Company Search